SERPINE1 and metabolic dysfunction-associated steatotic liver disease: In addition, elevated levels of plasminogen activator inhibitor-1 (PAI-1) in patients with NAFLD contribute to a prothrombotic state by inhibiting fibrinolysis, the natural process of the body to break down blood clots.